Table 4.
Discharge medications of the Gulf CARE cohort stratified by race.
| Medications at dischargea | All (n = 4106) | Indian subcontinent (n = 350) | Gulf citizen (n = 3756) | p value |
|---|---|---|---|---|
| Diuretics | 3862 (94%) | 322 (92%) | 3540 (94%) | 0.089 |
| Aldosterone antagonist | 1800 (44%) | 121 (35%) | 1679 (45%) | <0.001 |
| ACEI | 2510 (61%) | 215 (61%) | 2295 (61%) | 0.905 |
| ARB | 723 (18%) | 39 (11%) | 684 (18%) | 0.001 |
| Beta-blocker | 2925 (71%) | 251 (72%) | 2674 (71%) | 0.837 |
| Digoxin | 1045 (25%) | 86 (25%) | 959 (26%) | 0.693 |
| Nitrates | 1583 (39%) | 136 (39%) | 1447 (39%) | 0.903 |
| Hydralazine | 292 (7.1%) | 30 (8.6%) | 262 (7.0%) | 0.267 |
| Aspirin | 3344 (81%) | 302 (86%) | 3042 (81%) | 0.015 |
| Clopidogrel | 1538 (37%) | 200 (57%) | 1338 (36%) | <0.001 |
| Statin | 2955 (72%) | 290 (83%) | 2665 (71%) | <0.001 |
| CCB | 623 (15%) | 53 (15%) | 570 (15%) | 0.987 |
| Anticoagulant | 751 (18%) | 51 (15%) | 700 (19%) | 0.060 |
| Anti-arrhythmic | 195 (4.8%) | 15 (4.3%) | 180 (4.8%) | 0.670 |
| Ivabradine | 201 (4.9%) | 19 (5.4%) | 182 (4.9%) | 0.629 |
ACEI – angiotensin converting enzyme inhibitor; ARB – angiotensin receptor blocker; CCB – calcium channel blocker.
a
Medications at discharge excluded those that died (n = 296; 6.5%) as well as those that left against medical advice (n = 137; 3.0%) (LAMA) (n = 433 = 4539 − 4106). Analyses were performed using Pearson's chi-square.